Poison pill provisions in the articles: takeover defence, and what it costs
A poison pill is not a section of any statute. It is an arrangement embedded in the company articles, triggered automatically when an outside party crosses a defined holding threshold, designed to make a takeover expensive and unattractive. This page explains how the mechanism works, which versions exist, and the risk in adopting one.
“A poison pill is drafted in quiet times. In stormy times it is already late to amend the articles.”
Adv. Erez Sapir
What a poison pill is
A poison pill is a defence against a hostile takeover. The idea is simple: not to block the takeover, but to make it too expensive. The mechanism is embedded in the company articles in advance and triggers automatically on a defined event, without any fresh decision being needed at the critical moment.
The two words that explain everything are in advance and automatically. A defence that has to be approved once the takeover is already under way arrives too late, and sometimes has to be approved by an organ that is no longer under the control of the defending side. So the arrangement is written in quiet times.
An important clarification: poison pill is not a statutory term in Israel, and there is no section of the Companies Law bearing that name. It is a contractual and constitutional arrangement whose validity derives from general company law and from the duties of fairness and good faith.
Source: Companies Law, 5759-1999. Checked September 2026.
How the mechanism works: trigger and consequence
Every poison pill has exactly two components. A triggering event, and a consequence that operates when it occurs.
The trigger. Usually crossing a holding threshold, for example an acquisition of a defined percentage of the company shares by a party not approved in advance. Other events can be defined: an unapproved tender offer, a change of control in a holding entity, or accumulation of holdings by parties acting together.
The consequence. This is where the poison sits. The classic version gives every shareholder other than the acquirer a right to buy additional shares at a substantial discount. The result is immediate dilution of the acquirer: their stake shrinks, the cost of the takeover jumps, and the case for it disappears.
Drafting those two components is the entire job. A threshold set too low blocks a welcome investor as well. A consequence that is too severe makes the mechanism unreasonable and invites challenge. A threshold set too high triggers the defence only once it is already too late.
Types of pill
Flip-in. The common one. Existing shareholders other than the acquirer may buy shares at a discount. The acquirer is diluted.
Flip-over. Applies on a merger. If the target merges with the acquirer, target shareholders receive a right to buy shares of the acquirer at a discount. The harm moves to the other side.
Debt pill. A provision in the financing agreements under which a change of control accelerates the debt. The acquirer discovers they have bought a company that must repay everything tomorrow.
Board composition defences. A staggered board, where only some members are replaced each year, so that even an acquirer holding control cannot replace all of them at once.
Golden parachutes. Enhanced departure terms for office holders on a change of control, which raise the price of the acquisition. This is the most contested tool, because it benefits management rather than shareholders.
What is relevant to a private company
The poison pill developed in the public company world, where shares trade and can be accumulated on the market. In a private company the picture differs: there is no trading, and transfer is in any event subject to the restrictions in the articles.
So in a private company the effective defence is not the classic pill but control over transfer of shares: a right of first refusal, a prohibition on transfer without approval, tag along and drag along rights. These give complete control over who comes in.
That said, there are two scenarios in which a pill type component is relevant to a private company. The first, where a shareholder could lose control through an external event such as enforcement of a charge or an inheritance. The second, in companies planning a raise or a listing, where it is worth fixing the defence structure while there is still agreement.
More on transfer tools on the shareholder rights page and the corporate governance page.
The legal framework in Israel
There is no section of the Companies Law headed poison pill, and the arrangement is not regulated by that name. Its validity derives from three sources.
The articles. They are the constitutional document and the place for the arrangement. The majority required to amend them, and the timing of adoption, are decisive questions.
Duties of office holders. Section 252 duty of care and section 254 duty of loyalty. A board adopting a defence must be able to show it acted for the benefit of the company and not to preserve its own position. That is the weak point of every takeover defence.
Duties of shareholders. Section 192 requires good faith and customary conduct, and section 193 requires a controlling shareholder and a holder of a decisive vote to act fairly. A defence that in practice entrenches a controller at the expense of other shareholders is examined against those duties.
The practical conclusion: timing of adoption is everything. An arrangement fixed in quiet times, with broad agreement and with no concrete offer on the table, withstands scrutiny far better than one adopted hastily against a specific bidder.
Source: Companies Law, 5759-1999. Checked September 2026.
The risks and the criticism
Entrenching management. The central criticism: a takeover defence sometimes protects whoever manages rather than whoever owns. A takeover is also a disciplinary mechanism. Blocking it can preserve failing management.
Harm to shareholder value. Blocking an offer that would have benefited shareholders harms them directly.
Deterring investors. An investor considering entry also examines how to exit. Overly aggressive defences deter exactly the people you wanted to attract.
Exposure to challenge. An arrangement perceived as unreasonable, or as operated other than for the benefit of the company, is open to challenge, and sometimes to personal exposure for those who approved it.
A simple internal test: if the arrangement were triggered tomorrow, could you explain to a minority shareholder why it serves them. If not, it needs redrafting.
Alternatives worth considering first
In most cases we see, the need that prompted the poison pill question is met by simpler tools.
Transfer restrictions in the articles. A right of first refusal and a prohibition on transfer without approval. In a private company that is usually enough.
Shares with different voting rights. Separating the right to profit from the right to decide.
A shareholders agreement with a veto. A veto over allotment and change of control, achieved by agreement rather than by a punitive mechanism.
A staggered board. Slows turnover without touching anyone property rights.
The rule: start with the least aggressive tool that achieves the objective. A poison pill is the sharp instrument, and every sharp instrument is judged accordingly.
Legal support
We always start with the same question: what exactly are you defending against. An unwanted investor, loss of control through an external event, or an internal dispute. The answer determines whether a poison pill is needed at all, or whether a transfer restriction and a veto suffice. Where the arrangement is required, we draft it in quiet times, define the trigger and the consequence precisely, and document the board reasoning.
To reach us: 02-5953322 in Jerusalem, 03-3030430 in Tel Aviv, WhatsApp 050-4411343.
Frequently asked questions about poison pill provisions
What is a poison pill in company articles?
Is the poison pill regulated in the Companies Law?
Is it relevant to a private company?
What is the difference between a flip-in and a flip-over?
When should the arrangement be adopted?
What is the main risk?
All department pages
Business support, incorporation and licensing · Partnerships and non-profits · Shareholders and corporate governance
Legal support for businessesChoosing a business structureSetting up a limited companyBusiness licensingRegistered and unregistered partnershipsPartnership agreementRegistering a non-profitCorporate governancePersonal liability of officersShareholder rights and dutiesMinority shareholder oppressionPiercing the corporate veilThe agency problemPoison pill provisionsContracts and transactions · Liquidation, insolvency and debt collection
Non-disclosure agreementAgency agreementFranchise agreementRaising capital with a SAFEDue diligence before a purchaseVoluntary liquidation of a companyExpedited voluntary liquidationLiquidating an insolvent companyClawing back gifts in insolvencyDebt collection and creditor representationPersonal guaranteesWorried about losing control of the company you built?
Tell us what you are defending against and what the articles say today. We will say whether a defence mechanism is needed or a simpler tool will do.